Human Mesenchymal Stem Cells (hMSCs) as Targets of DNA Damaging Agents in Cancer Therapy

E-ISSN： 1873-5576|10|4|411-421

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.4, 2010-06, pp. : 411-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1909-1922

Bentham Science Publishers

Access to resources Recommend Favorite

Human Mesenchymal Stem Cells Promote Cancer Motility and Cytokine Secretion in vitro

Cells Tissues Organs, Vol. 198, Iss. 5, 2013-12 ,pp. : 327-337

Karger

Access to resources Recommend Favorite

Influence of environmental and genetic factors on variation in human response to DNA damaging agents

By Green M.H.L.

Environmental Toxicology and Pharmacology, Vol. 2, Iss. 2, 1996-10 ,pp. : 151-155

Elsevier

Access to resources Recommend Favorite

Role of MicroRNA 21 in Mesenchymal Stem Cell (MSC) Differentiation: A Powerful Biomarker in MSCs Derived Cells

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 1, 2015-01 ,pp. : 43-48

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Stem Cells and Cell Therapy for Bone Repair

Current Molecular Pharmacology, Vol. 9, Iss. 4, 2016-11 ,pp. : 289-299

Bentham Science Publishers

Access to resources Recommend Favorite